Recombinant PDCD1 (Tislelizumab Biosimilar) antibody

Catalog No. ABIN7488143

The Mammalian Cells Monoclonal anti-PDCD1 (Tislelizumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect PDCD1 (Tislelizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant PDCD1 (Tislelizumab Biosimilar) antibody (ABIN7488143)

Target: PDCD1 (Tislelizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This PDCD1 (Tislelizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-PDCD1 (Tislelizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Tislelizumab Biosimilar - Anti-PDCD1, PD1, CD279 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for PDCD1 (Tislelizumab Biosimilar)

Target: PDCD1 (Tislelizumab Biosimilar)

Target Type: Biosimilar

Background: BGB-A317
Tislelizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin.

CAS-No: 1858168-59-8